Literature DB >> 17676284

[R1 resection in the surgery of upper gastrointestinal tumors: relevance and therapeutic consequences].

F Lordick1, K Ott, A Novotny, C Schuhmacher, J R Siewert.   

Abstract

Microscopically involved tumor margins are an important problem in the surgery of locally advanced esophageal and gastric carcinomas. We conducted a systematic review of the literature and a specific analysis of our own patient database. This article summarizes current knowledge of the incidence and prognosis of R1 resections in upper gastrointestinal cancers. Preoperative strategies for reducing the rate of R1 resections are presented, and the surgical options in case of R1 resection are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17676284     DOI: 10.1007/s00104-007-1381-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  30 in total

Review 1.  Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.

Authors:  H L van Westreenen; M Westerterp; P M M Bossuyt; J Pruim; G W Sloof; J J B van Lanschot; H Groen; J Th M Plukker
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

2.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

3.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

5.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

6.  Role of endoscopic ultrasonography in esophageal carcinoma.

Authors:  H J Dittler; J R Siewert
Journal:  Endoscopy       Date:  1993-02       Impact factor: 10.093

Review 7.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  [Importance of tumor growth and spread for surgical radical excision].

Authors:  C Wittekind
Journal:  Zentralbl Chir       Date:  1993       Impact factor: 0.942

9.  Treatment outcomes of resected esophageal cancer.

Authors:  Wayne Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko R Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

10.  Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma.

Authors:  H Nekarda; C Gess; M Stark; J D Mueller; U Fink; U Schenck; J R Siewert
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  5 in total

Review 1.  [Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy].

Authors:  F Lordick; K Ott; A Sendler
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

Review 2.  Gastric cancer: surgery in 2011.

Authors:  Katja Ott; Florian Lordick; Susanne Blank; Markus Büchler
Journal:  Langenbecks Arch Surg       Date:  2011-01-14       Impact factor: 3.445

Review 3.  [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint].

Authors:  K Ott; F Lordick
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

Review 4.  [Principles of neoadjuvant therapy].

Authors:  F Lordick
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

5.  Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.

Authors:  Andreas-Claudius Hoffmann; Daniel Vallböhmer; Klaus Prenzel; Ralf Metzger; Michaela Heitmann; Susanne Neiss; Fredericke Ling; Arnulf H Hölscher; Paul M Schneider; Jan Brabender
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-04       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.